MyBillOfHealth helps health systems improve patient financial conversion through AI-powered digital engagement that builds trust, simplifies financial resolution, and increases self-pay recovery across the "recoverable middle".
They ignore them because they're confused, overwhelmed, uncertain, or afraid of overpaying. Confusion erodes payment. Uncertainty kills conversion. Silence ages into lost revenue., overwhelmed, uncertain, or afraid of overpaying. Confusion erodes payment. Uncertainty kills conversion. Silence ages into lost revenue.
Five engagement steps designed to convert confusion into confident payment — before balances age out of resolution.
Six capabilities that turn patient confusion into confident, on-platform financial resolution.
Most patients don't understand their bill — and that uncertainty drives delays, complaints, and lost revenue. We replace confusion with confidence: every balance explained in context, every option visible, every next step clear.
Many patient balances sit in the gap between self-resolution and aggressive collections. That gap is where preventable revenue loss is concentrated — and where the right engagement can recover the most.
MyBillOfHealth is purpose-built for the recoverable middle — the high-volume tier where AI-powered financial engagement outperforms both passive billing and aggressive collections, on conversion and on patient experience.
An intelligent assistant that explains balances in plain English, surfaces the right resolution at the right moment, and builds the kind of trust that drives self-pay conversion — available 24/7.
MyBillOfHealth MyBillOfHealth integrates with systems like MyChart and connects to your existing billing, payment, and assistance workflows — so engagement starts the moment a balance is generated.
CFO-aligned, operational, measurable. The patient experience your team delivers is also the engine of your revenue cycle.
Alpha-site partners get hands-on configuration, direct roadmap input, white-glove implementation, and preferred pricing at GA. Limited 2026 cohort.